Clinical trials recruiting for Pancreatic Adenocarcinoma Advanced or Metastatic
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 5-FU (5-fluorouracil) | 1 |
| CT-95 | 1 |
| Gemcitabine | 1 |
| INV-8989 | 1 |
| Irinotecan (CPT-11) | 1 |
| Leucovorin | 1 |
| Nab-paclitaxel | 1 |
| Oxaliplatin | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 1 |
| Illinois | 1 |
| Michigan | 1 |
| New Jersey | 1 |
| Pennsylvania | 1 |
| Tennessee | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
- CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
Related conditions
Trials recruiting for Pancreatic Adenocarcinoma Advanced or Metastatic often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Adenocarcinoma Advanced or Metastatic trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.